Predicting Invasive Lobular Carcinoma Prognosis Through Absence of Lobular Carcinoma in Situ

from Oncology Data Advisor · host i3 Health

In this interview, Dr. Jason Mouabbi speaks with Oncology Data Advisor about his research regarding the absence of lobular carcinoma in situ as a poor prognostic marker in invasive lobular carcinoma, which will be presented as a poster at the 2022 San Antonio Breast Cancer Symposium (SABCS).

Episode metadata supplied by the publisher feed · Published Dec 14, 2022

Embed this episode

Attribution link and audio player

NOW PLAYING

Predicting Invasive Lobular Carcinoma Prognosis Through Absence of Lobular Carcinoma in Situ

0:00 9:35

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Oncology Data Advisor?

This episode is 9 minutes long.

When was this Oncology Data Advisor episode published?

This episode was published on December 14, 2022.

Can I download this Oncology Data Advisor episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!